4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0000950170-24-017237
EVP, Chief Development Officer sold 5,847 shares at an average $1.33 ($7,783)
From the SEC's structured data for this filing
Trades in this filing
Poulton Stuart · EVP, Chief Development Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-15 | Sale : show line 1 in the form | −5,748 | $1.33 | $7,645 | 163,871 | D |
| 2024-02-15 | Sale : show line 2 in the form | −99 | $1.40 | $139 | 163,772 | D |
| Open-market sales · 5,847 sh · avg $1.33 · $7,783 | ||||||
Loading xslF345X05/ownership.xml…